A population study found declining prescription overlap, while its registry definition and dispensing measures limited broader conclusions.
The analysis examined registered First Nations people in Ontario during 2013–2021. Quarterly opioid dispensing for pain declined by 25%. Among people receiving an opioid for pain, concurrent benzodiazepine dispensing fell from 20.9% in the second quarter of 2013 to 16.7% in the fourth quarter of 2021. Patterns differed by age, sex and residence.
The registry did not include every Indigenous person or every First Nations person. Dispensing records did not establish consumption, access to unregulated drugs or the appropriateness of tapering. A reduction in overlap is not itself evidence that pain care improved, overdoses fell or prescribing changes were equitable.
For policy interpretation, preserve the study’s population boundaries and historical dates. Compare like denominators and consider access and unmet need alongside medication risk. The paper documents a prescribing trend; it should not be used to characterize an individual’s behavior or generalize one group’s experience to all Indigenous communities.
Source reviewed: Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations P (PMC13076853). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Automated Dispensing Began Near Increases in Medication Burden.